Company profile: Intrinsic Imaging
1.1 - Company Overview
Company description
- Provider of full-service medical imaging core lab solutions supporting Phase I-IV Clinical Trials and Class I-III Medical Device Trials. Services include study and site management across 4,000 imaging sites in 75 countries, optimized Imaging Charters, ISO-certified image acquisition protocols, and clinical trial imaging solutions for pharmaceutical, biotechnology, and medical device companies, including AI/CAD clinical trials.
Products and services
- Study Management: Full-service imaging core lab study management that architects and manages all imaging aspects for Phase I–IV clinical and Class I–III device trials, led by board-certified, fellowship-trained radiologists
- Site Management: Global-scale site management that administers over 4,000 imaging sites in 75 countries, qualifying and training each location for clinical trials across diverse geographies
- Image Acquisition Protocol: ISO-certified image acquisition protocols that ensure correct acquisition of participant images for clinical trials, implementing defined processes to achieve compliant capture and consistency
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Intrinsic Imaging
Suanfarma
HQ: Spain
Website
- Description: Provider of development, manufacturing, and distribution of raw materials and finished dosage forms for pharmaceutical, biotechnological, veterinary, nutritional, and cosmetic sectors. Offers human and veterinary APIs and generics across multiple therapeutic areas, CDMO services for fermentation and chemical synthesis under cGMP, predictive maintenance, and R&D on alternative synthesis routes and analytical methods.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Suanfarma company profile →
Zwiers Regulatory
HQ: The Netherlands
Website
- Description: Provider of consulting services focused on integrated development for pharmaceuticals and devices, pharmacovigilance, and regulatory affairs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Zwiers Regulatory company profile →
Veranova
HQ: United States
Website
- Description: Provider of research, development, and manufacturing of sophisticated, complex active pharmaceutical ingredients (APIs) for pharmaceutical and biotech industries, applying scientific expertise and diversified talent to create fresh approaches to resolving business issues and enhancing stakeholder value.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Veranova company profile →
Senn Chemicals
HQ: Switzerland
Website
- Description: Provider of peptide development and manufacturing services, spanning intermediates to CGMP API and supporting discovery through commercial production. In the peptide business since 1963, SENN offers expertise to optimize processes and streamline scale-up.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Senn Chemicals company profile →
Suazio
HQ: Belgium
Website
- Description: Provider of research and consultancy services offering customer insights, product value drivers, and economic value proposition services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Suazio company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Intrinsic Imaging
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Intrinsic Imaging
2.2 - Growth funds investing in similar companies to Intrinsic Imaging
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Intrinsic Imaging
4.2 - Public trading comparable groups for Intrinsic Imaging
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →